Key result
Apo A5 -1131T>C CC genotype is linked to ~6-fold higher risk of hypertriglyceridemia vs. TT.
Why the study?
The prevalence of hypertriglyceridemia is high in Taiwanese aborigines, and the effect of the -1131T>C polymorphism in the apolipoprotein A5 gene on serum triglyceride levels was unclear.
Is the -1131T>C polymorphism in the apolipoprotein A5 gene associated with hypertriglyceridemia in female Taiwanese aborigines?
Cross-Sectional (n=316)
Is the -1131T>C polymorphism in the apolipoprotein A5 gene associated with hypertriglyceridemia in female Taiwanese aborigines?
Odds Ratio: 5.86 (95% CI 2.15–15.99)
p-value: p=< 0.01
The -1131T>C polymorphism in the Apo A5 gene is independently associated with a significantly increased risk of hypertriglyceridemia in female Taiwanese aborigines.
May inform risk stratification in female Taiwanese aborigines; leaves open causality and clinical utility pending prospective validation.
The prevalence of hypertriglyceridemia, considered to be an independent risk factor for the development of cardiovascular disease, is high in Taiwanese aborigines. This study was undertaken to examine the effect of the -1131T>C polymorphism in the apolipoprotein A5 gene on serum triglyceride levels in female Taiwanese aborigines. This was a cross-sectional study, and a total of 316 unrelated female Taiwanese aborigines were genotyped at the -1131T>C polymorphism in apolipoprotein A5 using the polymerase chain reaction-restriction fragment length polymorphism method. Serum triglyceride > or = 150 mg/dL was defined as the hypertriglyceridemia group and triglyceride < 150 mg/dL was considered to be the control group. The frequency of the minor C allele was significantly higher in the hypertriglyceridemia group (0.53) than in the control group (0.35) (p < 0.001). The frequency of this rare allele was comparable to that in Japanese and Han Chinese, but was higher than that in Caucasians. In a multiple logistic model adjusted for possible confounders, C allele-containing variants were independently associated with greater risks (CT genotype: OR = 3.28, 95% CI = 1.43-7.56; CC genotype: OR = 5.86, 95% CI = 2.15-15.99) of hypertriglyceridemia than the TT genotype (p < 0.01), notably with the CC homozygote exhibiting the greatest risks. The genotype polymorphisms were also associated with serum triglyceride concentrations in a linear fashion (for trend, p < 0.05). Our results indicate that the -1131T>C polymorphism of the Apo A5 gene influences serum triglyceride levels in female Taiwanese aborigines, and that differences exist in the frequency of the C allele among people of various ethnicities.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2008) conducted a cross-sectional in Hypertriglyceridemia (n=316). -1131T>C polymorphism in the apolipoprotein A5 gene (CC genotype) vs. TT genotype was evaluated on Hypertriglyceridemia (serum triglyceride ≥ 150 mg/dL) (OR 5.86, 95% CI 2.15-15.99, p=< 0.01). The CC genotype of the -1131T>C polymorphism in the Apo A5 gene was associated with a significantly greater risk of hypertriglyceridemia compared to the TT genotype (OR 5.86; 95% CI 2.15-15.99).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: